Is atha a good stock now

Athira Pharma Inc (ATHA) is not currently a good stock investment for several reasons:

1. Recent Performance: The stock has experienced a significant drop, with a 75.09% slump in 2024, reaching a 52-week low of $0.41, indicating a strong bearish trend.
2. Market Sentiment: The stock has an overall negative sentiment with an average of 50% Sell ratings for short-term indicators and 100% Sell ratings for medium-term indicators, suggesting widespread pessimism among analysts.
3. Strategic Pivot: The company has had to pivot its strategy after disappointing results from its Phase 2/3 LIFT-AD trial, shifting focus from ATH-1017 to ATH-1105, which may impact its future prospects.
4. Financial Health Concerns: Athira Pharma has received a notification from Nasdaq stating that it does not meet the minimum bid price requirement, which could lead to delisting concerns.
5. Lack of Positive Earnings Outlook: The company is expected to report negative earnings per share (EPS) for the current and next year, with estimated EPS of -0.71 for the year and -0.71 for the next year.

In conclusion, the combination of poor recent performance, negative market sentiment, strategic shifts, financial health concerns, and lack of positive earnings outlook make ATHA a questionable investment at this time. Investors should exercise caution and consider these factors before investing in the stock.